Dr Baljevic on Advancements in the Management of Newly Diagnosed Multiple Myeloma

Muhamed Baljevic, MD, discusses key trial updates and advancements with quadruplet therapy in newly diagnosed multiple myeloma.

Related Keywords

Muhamed Baljevic ,Vanderbilt Amyloidosis Multidisciplinary Program ,Vanderbilt Ingram Cancer Center ,Division Of Hematology Oncology ,Hematology Oncology ,Plasma Cell Disorders Research ,Monitoring System ,Vanderbilt Stem Cell Transplant ,Cellular Therapy ,Intergroupe Francophone ,